FMR CORP 13D and 13G filings for Agios Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-09-12 11:13 am Sale |
2022-09-09 | 13G | Agios Pharmaceuticals, Inc. AGIO |
FMR CORP | 2,007,111 3.661% |
-3,427,202 (-63.07%) |
Filing |
| 2022-02-09 09:09 am Sale |
2022-02-08 | 13G | Agios Pharmaceuticals, Inc. AGIO |
FMR CORP | 5,434,313 10.006% |
-2,199,667 (-28.81%) |
Filing |
| 2021-03-10 09:46 am Purchase |
2021-03-09 | 13G | Agios Pharmaceuticals, Inc. AGIO |
FMR CORP | 7,633,980 10.968% |
3,295,314 (+75.95%) |
Filing |
| 2021-02-08 10:15 am Sale |
2021-02-05 | 13G | Agios Pharmaceuticals, Inc. AGIO |
FMR CORP | 4,338,666 6.264% |
-204,140 (-4.49%) |
Filing |
| 2020-08-10 09:25 am Sale |
2020-08-07 | 13G | Agios Pharmaceuticals, Inc. AGIO |
FMR CORP | 4,542,806 6.573% |
-4,285,656 (-48.54%) |
Filing |